Godavari Drugs Converts Warrants into Equity

7,86,690 Equity Shares Allotted
Rs. 89 Per Share Issue Price

Reader Takeaway: Promoters convert warrants, boosting equity. Monitor remaining warrants for future dilution.

What just happened

Godavari Drugs Ltd announced the allotment of 7,86,690 equity shares to its promoter category. This move follows the conversion of an equal number of warrants. The issue price for these shares was fixed at Rs. 89 per share.

The company received the remaining 75% payment, approximately Rs. 5.25 crore, to finalize the conversion.

Why this matters

This allotment has increased Godavari Drugs' paid-up equity capital from Rs. 10,12,74,350 to Rs. 10,91,41,250. The total number of outstanding shares also rose from 1,01,27,435 to 1,09,14,125.

This change in capital structure impacts shareholder equity and earnings per share calculations.

The backstory

The warrants converted were originally issued after approval at an Extra-ordinary General Meeting (EGM) on February 12, 2026.
The Board of Directors approved this specific allotment on August 14, 2026.

What changes now

The company's paid-up equity capital and total outstanding shares have been updated.

Risks to watch

There are still 15,73,375 warrants outstanding. These can be converted within 18 months.

Conversion of these remaining warrants will further increase the equity base, potentially diluting existing shareholders' stakes.

Context metrics (time-bound)

• Allotment Date: August 14, 2026
• Issue Price: Rs. 89 per share
• Amount Received: Approx. Rs. 5.25 crore (75% payment)
• Pre-Allotment Paid-up Capital: Rs. 10,12,74,350
• Post-Allotment Paid-up Capital: Rs. 10,91,41,250
• Pre-Allotment Shares: 1,01,27,435
• Post-Allotment Shares: 1,09,14,125
• Outstanding Warrants: 15,73,375
• Remaining Conversion Price: Rs. 66.75 per warrant (75% of issue price)
• Timeframe for Remaining Conversion: 18 months from original allotment.